Cargando…
Affibody-Binding Ligands
While antibodies remain established therapeutic and diagnostic tools, other protein scaffolds are emerging as effective and safer alternatives. Affibodies in particular are a new class of small proteins marketed as bio-analytic reagents. They feature tailorable binding affinity, low immunogenicity,...
Autores principales: | Barozzi, Annalisa, Lavoie, R. Ashton, Day, Kevin N., Prodromou, Raphael, Menegatti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312911/ https://www.ncbi.nlm.nih.gov/pubmed/32471034 http://dx.doi.org/10.3390/ijms21113769 |
Ejemplares similares
-
Affordable Microfluidic Bead-Sorting Platform for Automated Selection of Porous Particles Functionalized with Bioactive Compounds
por: Saberi-Bosari, Sahand, et al.
Publicado: (2019) -
Targeted Capture of Chinese Hamster Ovary Host Cell Proteins: Peptide Ligand Discovery
por: Lavoie, R. Ashton, et al.
Publicado: (2019) -
Recombinant amyloid beta-peptide production by coexpression with an affibody ligand
por: Macao, Bertil, et al.
Publicado: (2008) -
Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity
por: Fleetwood, Filippa, et al.
Publicado: (2014) -
Prokaryotic expression of antibodies and affibodies
por: Fernández, Luis Angel
Publicado: (2004)